Beghou appoints Meredith Ressi as president and chief growth officer

Beghou, a Chicago-headquartered life sciences consulting firm, has appointed its chief growth officer Meredith Ressi as president and chief growth officer.

In the expanded role, Ressi will drive the firm’s client experience – from go-to-market to solution delivery and long-term partnerships – as well as ensure Beghou’s people, processes, and technology are optimized to solve client challenges.

“It has been my absolute pleasure to work alongside Meredith and learn from her insights and experience here at Beghou,” said Adrienne Lovink, CEO of Beghou. “Now, in this expanded role, she’ll ensure that we continue to scale intelligently and with purpose so that clients always have access to the right people and technology to achieve their goals.”

Ressi has more than 20 years of experience in driving growth at life sciences and digital health companies, including crafting and executing strategic development and innovation plans, helping companies connect more deeply with customers, and improving how therapies reach and serve patients.

She joined Beghou in March 2024 as chief growth officer. Before that, Ressi spent two years as chief operating officer at ClearSight Health and 10 years at Decision Resources Group (now Clarivate), where she was chief commercial officer. Earlier in her career, she was VP of research at Manhattan Research (now Clarivate) and VP of business development at Nutricise.

Ressi has a bachelor’s degree in economics and urban studies from Brown University.

Beghou was founded in 1993 and specializes in life sciences commercialization. The firm has practices in commercial operations support, marketing research, segmentation and targeting, sales force design, incentive compensation, forecasting, and data and analytics.

Beghou has more than 400 professionals across 10 offices in the US and India.

The firm recently welcomed Jenny Herritz and Marcos Mendell as partners.